Your browser doesn't support javascript.
loading
The effect of social determinants of health on utilization of surgical treatment for hepatocellular carcinoma patients.
Murthy, Shilpa S; Ortiz, Angel; DuBois, Tesla; Sorice, Kristen A; Nguyen, Minhhuyen; Castellanos, Jason A; Pinheiro, Paulo; Gonzalez, Evelyn T; Lynch, Shannon M.
Afiliação
  • Murthy SS; St James University Hospital, Leeds, United Kingdom.
  • Ortiz A; Fox Chase Cancer Center, Philadelphia, PA, USA.
  • DuBois T; Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Sorice KA; Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Nguyen M; Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Castellanos JA; Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Pinheiro P; University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL, USA.
  • Gonzalez ET; Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Lynch SM; Fox Chase Cancer Center, Philadelphia, PA, USA. Electronic address: shannon.Lynch@fccc.edu.
Am J Surg ; 225(4): 715-723, 2023 04.
Article em En | MEDLINE | ID: mdl-36344305
BACKGROUND: A paucity of data exists on how social determinants of health (SDOH) influence treatment for Hepatocellular carcinoma (HCC). We investigated associations between SDOH (healthcare access, education, social/community context, economic stability, and built/neighborhood environment) and receipt of surgery. METHODS: The Pennsylvania Liver Cancer Registry was linked with neighborhood SDOH from the American Community Survey. Multilevel logistic regression models with patient and neighborhood SDOH variables were developed. RESULTS: Of 9423 HCC patients, 2393 were stage I. Only 36.3% of stage I patients received surgery. Black patients had significantly lower odds of surgery vs Whites (OR = 0.73; p < 0.01), but not after adjustments for SDOH. All 5 SDOH domains were associated with odds of surgery overall; 2 domains were associated in Stage I patients, social context (e.g., racial concentration, p = 0.03) and insurance access (p < 0.01). CONCLUSIONS: SDOH impact utilization of surgery for HCC. Findings can guide healthcare professionals to create programs for populations at risk for poor liver cancer outcomes.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Revista: Am J Surg Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Revista: Am J Surg Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido